Assessment of myocardial perfusion with contrast echocardiography at rest and with stress: An emerging technology

Progress in Cardiovascular Diseases

Volumn 43, Issue 3, 2000, Pages 245-258

  Laskar, Raja ^a   Grayburn, Paul A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUSPHERES; ADENOSINE; ALBUMEX; ALBUMIN; BISPHERES; ECHO CONTRAST MEDIUM; FS 069; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NC 100100; OCTAFLUOROPROPANE; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; PERFLUTREN; PESDA; SHU 508; SONOGEN; SONOVUE; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0034534302     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.19802     Document Type: Article

References (81)

1. Echocardiography of the aortic root
2. Echocardiographic visualization of myocardial perfusion by left heart and intracoronary injecjtions of contrast agents
3. A new method of producing echo contrast agents capable of capillary transit
4. Detecting intrapulmonary right-to-left shunts with contrast echocardiography
5. Contrast M-mode echocardiography in diagnosis of atrial septal defect in acyanotic patients
6. In vivo myocardial kinetics of air filled albumin microbubbles during myocardial contrast echocardiography
7. Albunex microbubbles mimic red blood cell transit through the myocardium
8. In vivo correlation of thermodilution cardiac output and videodensitormetric indicator-dilution curves obtained from contrast 2-dimensional echocardiograms
9. Method for quantitation of myocardial perfusion during myocardial contrast two dimensional echocardiography
10. Quantifying myocardial blood flow with contrast echocardiography
11. Changes in myocardial blood volume with graded coronary stenosis
12. Contrast echocardiography measures intramyocardial blood volume, not blood flow
13. Why do we need contrast agents for ultrasound?
14. Why do the lungs clear ultrasound contrast?
15. Neutrophil kinetics and lung injury
16. Intraveous perfluoropropaneexposed sonicated dextrose albumin produces myocardial contrast which correlates with coronary blood flow
17. Myocardial contrast echocardiography during acute myocardial infarction using intermittent harmonic imaging and intravenous MRX-115
18. Hemodynamic characteristics, myocardial kinetics, and microvascular rheology of FS-069, a second generation echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow reserve
19. Second harmonic imaging of an intravenously administered echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow reserve
20. Effect of pressure on echocardiographic videointensity from sonicated albumin. An in vitro model
21. Pulsatile pressure affects the disappearance of echocardiographic contrast agents
22. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents
23. Ultrasound-mediated destruction of contrast agents: Effect of ultrasound intensity, exposure, and frequency
24. Destruction of contrast microbubbles during ultrasound imaging at conventional power output
25. Increased ultrasound contrast and decreased ultrasound destruction rates with triggered ultrasound imaging
26. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: Demonstration and potential mechanisms
27. Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose
28. Interactions between microbubbles and ultrasound: In vitro and in vivo observations
29. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality
30. Harmonic imaging: Principles and preliminary results
31. Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent
32. Second harmonic ultrasound blood perfusion measurement
33. Tissue harmonic imaging. Why does it work?
34. Principles and recent developments in ultrasound contrast agents
35. Relation of contrast echo intensity and flow velocity to the amplication of contrast opacification produced by intermittent ultrasound
36. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging
37. Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging
38. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent
39. Stimulated acoustic emission-nonbackscatter contrast effect of microbubbles seen with harmonic power Doppler imaging
40. Harmonic power Doppler contrast echocardiography preliminary experimental results
41. Power Doppler ultrasound. A potentially useful alternative to mean frequency based color Doppler sonography
42. Acoustically stimulated transient power scattering explains enhanced detection of the very low velocities in myocardial capillaries by power Doppler imaging: An in vitro study
43. Quantification of myocardial perfusion with myocardial contrast echocardiography from left atrial injection of contrast: Implications for venous injection
44. Myocardial contrast echocardiography can be used to quantify intramyocardial blood volume. New insights into structural mechanisms of coronary autoregulation
45. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion
46. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecofluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia
47. Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography
48. Detection of myocardial perfusion defects by contrast echocardiography in the setting of acute myocardial ischemia with residual antegrade flow
49. Assessment of myocardial perfusion by contrast echocardiography: II. Detection of changes in transmural and sub-endocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis
50. Detection of coronary stenosis using venous injection of FSO69 with intermittent harmonic imaging
51. Detection of coronary artery stenoses and quantification of blood flow mismatch during coronary hyperemia and myocardial contrast echocardiography
52. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second generation echocardiographic contrast agent
53. Detection of coronary artery disease with myocardial contrast echocardiography: Comparison with 99mTc-sestamibi single-photon emission computed tomography
54. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice. Comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography
55. Myocardial contrast echocardiography: Too much, too soon?
56. Power Doppler harmonic imaging: A feasibility study of a new technique for the assessment of myocardial perfusion
57. Assessment of myocardial perfusion by power Doppler harmonic imaging at rest and during adenosine stress
58. Myocardial perfusion studied by power Doppler imaging in patients with a recent myocardial infarction
59. The "no-reflow" phenomenon after temporary coronary occlusion in the dog
60. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion. Which comes first?
61. Regional distribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog
62. Effects of coronary reperfusion on regional myocardial blood flow and function in conscious baboons
63. Lack of myocardial perfusion immediately after successful thrmoblysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction
64. Illusion of reperfusion: Does anyone achieve optimal reperfusion during acute myocardial infarction?
65. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: A myocardial contrast echocardiography study
66. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography
67. Ability of no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one month follow-up
68. Prediction of short- and intermediate-term prognosis of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization
69. Accuracy and limitations of exercise echocardiography in a routine clinical setting
70. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease
71. Assessmerit of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography
72. Effect of contrast-enhancement on transthoracic echocardio graphic assessment of left ventricular regional wall motion
73. Influence of coronary collaterals on left ventricular function in patients undergoing coronary angioplasty
74. Late thrombolytic therapy Preserves left ventricular function in patients with collateralized total coronary occlusion: Primary end point findings of the second Mount Sinai New York University reperfusion trial
75. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
76. Myocardial contrast echocardiography demonstrates that collateral flow can preserve myocardial function beyond a chronically occluded coronary artery
77. Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function post revascularization: A study using the combination of myocardial contrast echocardiography and dobutamine echocardiography
78. Comparison of myocardial contrast echocardiography and lowdose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease
79. Reversible asynergy: Histopathological and electrocardiological correlations in patients with coronary artery disease
80. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium